Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratympanic dexamethasone phosphate versus triamcinolone acetonide for Meniere's disease
2018-001958-10Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Aug 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Meniere Disease comparing Triamcinolone acetonide with Dexamethasone sodium phosphate (2 arms). Primary endpoint: Vertigo control rate at 24 months. Started Aug 2018; status: completed.
02
Drugs
triamcinolone acetonidedexamethasone sodium phosphate
03
Conditions
Meniere Disease
Beyond the preview
Go deeper on 2018-001958-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001958-10.